Stock listing

Cellbxhealth Plc

Selected listing: CLBX · LSE · GBX · GB

Cellbxhealth Plc (LSE:CLBX), Distribution Services. Latest release Aug 11, 2026: Parsortix CTCs used for Brain Cancer detection.

CLBX:LSEGBXGBUpdated October 3, 2026

Ticker: LSE:CLBX
Asset type: Stock
Sector: Distribution Services
Industry: Medical Distributors
Exchange: LSE
Currency: GBX

About Cellbxhealth Plc

The company focuses on health-related innovations and solutions. As a publicly traded entity, it aims to enhance its presence in the healthcare sector.

Latest news from Cellbxhealth Plc

Parsortix CTCs used for Brain Cancer detection

August 11, 2026

Parsortix CTCs used for ADC target assessment

August 3, 2026

Q2 and First Half Year Results ended 30 June 2026

July 15, 2026

Directorate change

July 6, 2026

MSA with Global Pharmaceutical Company

May 29, 2026

All Cellbxhealth Plc news →

Events

Replays

CELLBXHEALTH PLC (CLBX) — Preliminary results for the year ended 31 December 2025
Mon, Jun 22, 2026 · 06:00 AM ET
Watch
CELLBXHEALTH PLC (CLBX) — Investor Presentation and Q&A
Wed, Nov 26, 2025 · 09:00 AM ET
Watch
CELLBXHEALTH PLC (CLBX) — Investor Presentation
Fri, Apr 28, 2023 · 06:00 AM ET
Watch

Research Cellbxhealth Plc

Cellbxhealth Plc company profile

View the public company page for Cellbxhealth Plc on 6ix.

Cellbxhealth Plc news

Read company news and market updates connected to Cellbxhealth Plc.

Cellbxhealth Plc investor events

Find investor webinars, events, and replay context for Cellbxhealth Plc.